Literature DB >> 31957517

A phase II clinical trial of lenalidomide intensification in patients with serologic/asymptomatic progression of multiple myeloma while on lenalidomide maintenance: a tri-state transplant consortium study.

Hani Hassoun1, Ruthee Bayer2, Sean Devlin1, Theresa Gentile3, Michael Becker4, Kristen O'Dweyer5, Martin Lesser6, Heather Landau7, David Chung8, Sergio Giralt9.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 31957517      PMCID： PMC7580780          DOI： 10.1080/10428194.2019.1672058

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN： 1026-8022


× No keyword cloud information.
  10 in total

1.  International Myeloma Working Group consensus approach to the treatment of multiple myeloma patients who are candidates for autologous stem cell transplantation.

Authors:  Michele Cavo; S Vincent Rajkumar; Antonio Palumbo; Philippe Moreau; Robert Orlowski; Joan Bladé; Orhan Sezer; Heinz Ludwig; Meletios A Dimopoulos; Michel Attal; Pieter Sonneveld; Mario Boccadoro; Kenneth C Anderson; Paul G Richardson; William Bensinger; Hans E Johnsen; Nicolaus Kroeger; Gösta Gahrton; P Leif Bergsagel; David H Vesole; Hermann Einsele; Sundar Jagannath; Ruben Niesvizky; Brian G M Durie; Jesus San Miguel; Sagar Lonial
Journal:  Blood       Date:  2011-03-29       Impact factor: 22.113

2.  Different patterns of relapse after autologous peripheral blood stem cell transplantation in multiple myeloma: clinical results of 280 cases from the Spanish Registry.

Authors:  Adrián Alegre; Asunción Granda; Carmen Martínez-Chamorro; Joaquín Díaz-Mediavilla; Rafael Martínez; José García-Laraña; Juan-José Lahuerta; Anna Sureda; Joan Bladé; Javier de la Rubia; José Maria Fernández-Rañada; Jesús San Miguel
Journal:  Haematologica       Date:  2002-06       Impact factor: 9.941

3.  Autologous transplantation and maintenance therapy in multiple myeloma.

Authors:  Antonio Palumbo; Federica Cavallo; Francesca Gay; Francesco Di Raimondo; Dina Ben Yehuda; Maria Teresa Petrucci; Sara Pezzatti; Tommaso Caravita; Chiara Cerrato; Elena Ribakovsky; Mariella Genuardi; Anna Cafro; Magda Marcatti; Lucio Catalano; Massimo Offidani; Angelo Michele Carella; Elena Zamagni; Francesca Patriarca; Pellegrino Musto; Andrea Evangelista; Giovannino Ciccone; Paola Omedé; Claudia Crippa; Paolo Corradini; Arnon Nagler; Mario Boccadoro; Michele Cavo
Journal:  N Engl J Med       Date:  2014-09-04       Impact factor: 91.245

4.  Patterns of relapse and progression in multiple myeloma patients after auto-SCT: implications for patients' monitoring after transplantation.

Authors:  D Zamarin; S Giralt; H Landau; N Lendvai; A Lesokhin; D Chung; G Koehne; D Chimento; S M Devlin; E Riedel; M Bhutani; D Babu; H Hassoun
Journal:  Bone Marrow Transplant       Date:  2012-08-13       Impact factor: 5.483

5.  Intensive therapy for multiple myeloma in patients younger than 60 years. Long-term results focusing on the effect of the degree of response on survival and relapse pattern after transplantation.

Authors:  Stig Lenhoff; Martin Hjorth; Ingemar Turesson; Jan Westin; Peter Gimsing; Finn Wislöff; Lucia Ahlberg; Kristina Carlson; Ilse Christiansen; Inger Marie Dahl; Karin Forsberg; Lorentz Brinch; Jens Hammerström; Hans E Johnsen; Lene Meldgaard Knudsen; Olle Linder; Ulf-Henrik Mellqvist; Ingerid Nesthus; Johan Lanng Nielsen
Journal:  Haematologica       Date:  2006-09       Impact factor: 9.941

6.  Lenalidomide Maintenance After Autologous Stem-Cell Transplantation in Newly Diagnosed Multiple Myeloma: A Meta-Analysis.

Authors:  Philip L McCarthy; Sarah A Holstein; Maria Teresa Petrucci; Paul G Richardson; Cyrille Hulin; Patrizia Tosi; Sara Bringhen; Pellegrino Musto; Kenneth C Anderson; Denis Caillot; Francesca Gay; Philippe Moreau; Gerald Marit; Sin-Ho Jung; Zhinuan Yu; Benjamin Winograd; Robert D Knight; Antonio Palumbo; Michel Attal
Journal:  J Clin Oncol       Date:  2017-07-25       Impact factor: 44.544

7.  Lenalidomide maintenance after stem-cell transplantation for multiple myeloma.

Authors:  Michel Attal; Valerie Lauwers-Cances; Gerald Marit; Denis Caillot; Philippe Moreau; Thierry Facon; Anne Marie Stoppa; Cyrille Hulin; Lofti Benboubker; Laurent Garderet; Olivier Decaux; Serge Leyvraz; Marie-Christiane Vekemans; Laurent Voillat; Mauricette Michallet; Brigitte Pegourie; Charles Dumontet; Murielle Roussel; Xavier Leleu; Claire Mathiot; Catherine Payen; Hervé Avet-Loiseau; Jean-Luc Harousseau
Journal:  N Engl J Med       Date:  2012-05-10       Impact factor: 91.245

8.  Lenalidomide after stem-cell transplantation for multiple myeloma.

Authors:  Philip L McCarthy; Kouros Owzar; Craig C Hofmeister; David D Hurd; Hani Hassoun; Paul G Richardson; Sergio Giralt; Edward A Stadtmauer; Daniel J Weisdorf; Ravi Vij; Jan S Moreb; Natalie Scott Callander; Koen Van Besien; Teresa Gentile; Luis Isola; Richard T Maziarz; Don A Gabriel; Asad Bashey; Heather Landau; Thomas Martin; Muzaffar H Qazilbash; Denise Levitan; Brian McClune; Robert Schlossman; Vera Hars; John Postiglione; Chen Jiang; Elizabeth Bennett; Susan Barry; Linda Bressler; Michael Kelly; Michele Seiler; Cara Rosenbaum; Parameswaran Hari; Marcelo C Pasquini; Mary M Horowitz; Thomas C Shea; Steven M Devine; Kenneth C Anderson; Charles Linker
Journal:  N Engl J Med       Date:  2012-05-10       Impact factor: 91.245

9.  Trends in pre- and post-transplant therapies with first autologous hematopoietic cell transplantation among patients with multiple myeloma in the United States, 2004-2014.

Authors:  A D'Souza; M-J Zhang; J Huang; M Fei; M Pasquini; M Hamadani; P Hari
Journal:  Leukemia       Date:  2017-06-13       Impact factor: 11.528

Review 10.  Management of relapsed and refractory multiple myeloma: novel agents, antibodies, immunotherapies and beyond.

Authors:  C S Chim; S K Kumar; R Z Orlowski; G Cook; P G Richardson; M A Gertz; S Giralt; M V Mateos; X Leleu; K C Anderson
Journal:  Leukemia       Date:  2017-11-16       Impact factor: 11.528
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.